IP Library Granted Patent US 9,559,321
Granted Patent B2
US 9,559,321 · App. 14/001,307 · Granted Jan 31, 2017

Metal complexes for use as dopants and other uses

Inventors: Julian Burschka (St-Sulpice, CH); Florian Kessler (Höchstadt an der Aisch, DE); Etienne Baranoff (Birmingham, GB); Mohammad Khaja Nazeeruddin (Ecublens, CH); Michael Graetzel (St-Sulpice, CH)
Assignee: Ecole Polytechnique Federale de Lausanne (EPFL)
H01L51/42C09K9/02C09K11/06H01L51/002H01L51/0083H01L51/50H01M4/60H01M4/624H01M6/14H01M10/05H01M10/4235C09K2211/1029C09K2211/1044C09K2211/187H01G9/2018H01G9/2031H01G9/2059H01G9/2095H01L51/4226H01L51/5032H01L51/5056H01L51/5072Y02E10/549
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,559,321
App. No.
14/001,307
Granted
Jan 31, 2017
Kind
B2
Abstract

The invention relates to electrochemical devices comprising complexes of cobalt comprising at least one ligand with a 5- or six membered, N-containing heteroring. The complex are useful as p- and n-dopants, as over of electrochemical devices, in particular in organic semiconductors. The complexes are further useful as over-discharge prevention and overvoltage protection agents.

Claims (56)

1. A complex of formula (I):

M(La) n (Xb) m   (I)

being a dopant,

wherein:

M is a metal selected from Co;

n is an integer from 1 to 6 and a is a consecutive number of a first set consisting of the integers of 1 to n (1, . . . , n), so that there are n ligands L1, . . . , Ln;

m is 0 or an integer from 1 to 5 and b is a consecutive number of a second set consisting of 0 and integers of 1 to m (0, . . . , m), so that if m>0 there are m ligands X1, . . . , Xm;

wherein n and m equal the appropriate number of ligands present on metal M;

wherein any La (L1, . . . , Ln) is independently selected from a mono-, bi-, or tridentate ligand, with the proviso that at least one of said ligands La (L1, . . . , Ln) is, independently, selected from compounds of formulae (1-3) to (3-3) below:

wherein, said ligand comprises at least one substituent R 1 , R 5 , and/or R 8 , as applicable, being selected independently from the substituent (A-1) to (G-2) below:

wherein:

the dotted line represents the bond connecting the substituent of (A-1) to (G-2)) on the compound of formula (1-3), (2-3) or (3-3); and,

substituents R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 , in as far as present, are independently selected from H, halogen, —NO 2 , —OH, —NH 2 , and from hydrocarbons comprising 1 to 30 carbons and 0 to 15 heteroatoms;

R′ of substituents (B-10), (C-9), (C-12), (C-14), and (C-16) is selected from C1-C5 alkyl;

wherein at least 3 ligands La are of identical structure (L1=L2=L3); and

Xb is a monodentate co-ligand independently selected from H 2 O, Cl − , Br − , I − , CN, NCO, NCS, NCSe, NH 3 , NR 7 R 8 R 9 , and PR 7 R 8 R 9 , wherein R 7 , R 8 , and R 9 are selected independently from substituted or unsubstituted alkyl, alkenyl, alkynyl and aryl.

2. The complex according to claim 1 , wherein n is 3 (M L1 L2 L3) and m is 0.

3. The complex according to claim 1 , which is cationic.

4. The complex according to claim 3 , which is provided together with a suitable anionic species selected from the group consisting of halogen (Cl − , Br − , F − ), CN − , NCO − , NCS − , NCSe − , ClO 4 − (perchlorate), PF 6 (hexafluorophosphate), BF 4 (tetrafluoroborate), B(CN) 4 (tetracyanoborate), CF 3 SO 3 (trifluoromethanesulfonate, triflate), (CF 3 SO 2 ) 2 N (Bis(trifluoromethane)sulfonamide, TFSI), B(C 6 H 3 (m-CF 3 ) 2 ) 4 (tetrakis[3,5-bis(trifluoromethyl)phenyl]borate, BARF), B(C 6 F 5 ) 4 (tetrakis(pentafluorophenyl)borate), B(Ph) 4 (tetraphenylborate), Al(OC(CF 3 ) 3 ) 4 , and CB 11 H 12 (carborane anion).

5. A complex of formula (I):

M(La) n (Xb) m   (I)

being a dopant,

wherein:

M is a metal selected from Co;

n is an integer from 1 to 6 and a is a consecutive number of a first set consisting of the integers of 1 to n (1, . . . , n), so that there are n ligands L1, . . . , Ln;

m is 0 or an integer from 1 to 5 and b is a consecutive number of a second set consisting of 0 and integers of 1 to m (0, . . . , m), so that if m>0 there are m ligands X1, . . . , Xm;

wherein n and m equal the appropriate number of ligands present on metal M;

wherein any La (L1, . . . , Ln) is independently selected from a mono-, bi-, or tridentate ligand, with the proviso that at least one of said ligands La (L1, . . . , Ln) is, independently, selected from compounds of formulae (1-3) to (3-3) below:

wherein, said ligand comprises at least one substituent R 1 , R 5 , and/or R 8 , as applicable, being selected independently from the substituent (A-1) to (G-2) below:

wherein:

the dotted line represents the bond connecting the substituent of (A-1) to (G-2)) on the compound of formula (1-3), (2-3) or (3-3); and,

substituents R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 , in as far as present, are independently selected from H, halogen, —NO 2 , —OH, —NH 2 , and from hydrocarbons comprising 1 to 30 carbons and 0 to 15 heteroatoms;

R′ of substituents (B-10), (C-9), (C-12), (C-14), and (C-16) is selected from C1-C5 alkyl;

Xb is a monodentate co-ligand independently selected from H 2 O, Cl − , Br − , I − , CN, NCO, NCS, NCSe, NH 3 , NR 7 R 8 R 9 , and PR 7 R 8 R 9 , wherein R 7 , R 8 , and R 9 are selected independently from substituted or unsubstituted alkyl, alkenyl, alkynyl and aryl; and

wherein said complex of formula (I) is cationic.

6. The complex according to claim 5 , wherein n is 2 (M L1 L2) or 3 (M L1 L2 L3) and m is 0.

7. The complex according to claim 5 , which comprises at least 3 ligands La of identical structure (L1=L2=L3).

8. The complex according to claim 5 , which is provided together with a suitable anionic species selected from the group consisting of halogen (Cl − , Br − , I − ), CN − , NCO − , NCS − , NCSe − , ClO 4 − (perchlorate), PF 6 (hexafluorophosphate), BF 4 (tetrafluoroborate), B(CN) 4 (tetracyanoborate), CF 3 SO 3 (trifluoromethanesulfonate, triflate), (CF 3 SO 2 ) 2 N (Bis(trifluoromethane)sulfonamide, TFSI), B(C 6 H 3 (m-CF 3 ) 2 ) 4 (tetrakis[3,5-bis(trifluoromethyl)phenyl]borate, BARF), B(C 6 F 5 ) 4 (tetrakis(pentafluorophenyl)borate), B(Ph) 4 (tetraphenylborate), Al(OC(CF 3 ) 3 ) 4 , and CB 11 H 12 (carborane anion).

9. A complex of formula (I):

M(La) n (Xb) m   (I)

being a dopant,

wherein:

M is a metal selected from Co;

n is an integer from 1 to 6 and a is a consecutive number of a first set consisting of the integers of 1 to n (1, . . . , n), so that there are n ligands L1, . . . , Ln;

m is 0 or an integer from 1 to 5 and b is a consecutive number of a second set consisting of 0 and integers of 1 to m (0, m), so that if m>0 there are m ligands X1, . . . , Xm;

wherein n and m equal the appropriate number of ligands present on metal M;

wherein any La (L1, . . . , Ln) is independently selected from a mono-, bi-, or tridentate ligand, with the proviso that at least one of said ligands La (L1, . . . , Ln) is, independently, selected from compounds of formulae (1-3) to (3-3) below:

wherein, said ligand comprises at least one substituent R 1 , R 5 , and/or R 8 , as applicable, being selected independently from the substituent (A-1) to (G-2) below:

wherein:

the dotted line represents the bond connecting the substituent of (A-1) to (G-2)) on the compound of formula (1-3), (2-3) or (3-3); and,

substituents R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 , in as far as present, are independently selected from H, halogen, —NO 2 , —OH, —NH 2 , and from hydrocarbons comprising 1 to 30 carbons and 0 to 15 heteroatoms;

R′ of substituents (B-10), (C-9), (C-12), (C-14), and (C-16) is selected from C1-C5 alkyl;

Xb is a monodentate co-ligand independently selected from H 2 O, Cl − , Br − , I − , CN, NCO, NCS, NCSe, NH 3 , NR 7 R 8 R 9 , and PR 7 R 8 R 9 , wherein R 7 , R 8 , and R 9 are selected independently from substituted or unsubstituted alkyl, alkenyl, alkynyl and aryl; and

wherein said complex of formula (I) is cationic and is provided together with a suitable anionic species selected from the group consisting of halogen (Cl − , Br − , I − ), CN − , NCO − , NCS − , NCSe − , ClO 4 − (perchlorate), PF 6 (hexafluorophosphate), BF 4 (tetrafluoroborate), B(CN) 4 (tetracyanoborate), CF 3 SO 3 (trifluoromethanesulfonate, triflate), (CF 3 SO 2 ) 2 N (Bis(trifluoromethane)sulfonamide, TFSI), B(C 6 H 3 (m-CF 3 ) 2 ) 4 (tetrakis[3, 5-bis(trifluoromethyl)phenyl]borate, BARF), B(C 6 F 5 ) 4 (tetrakis(pentafluorophenyl)borate), B(Ph) 4 (tetraphenylborate), Al(OC(CF 3 ) 3 ) 4 , and CB 11 H 12 (carborane anion).

10. The complex according to claim 9 , wherein n is 2 (M L1 L2) or 3 (M L1 L2 L3) and m is 0.

11. The complex according to claim 9 , which comprises at least 3 ligands La of identical structure (L1=L2=L3).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2013
From: BARANOFF, ETIENNE
To: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
Reel/Frame 031417/0620 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2013
From: BURSCHKA, JULIAN; KESSLER, FLORIAN; NAZEERUDDIN, MOHAMMAD KHAJA; GRAETZEL, MICHAEL
To: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
Reel/Frame 031088/0345 →
Priority Claims (4)
EP 11156029 · Feb 25, 2011 · regional
EP 11161739 · Apr 8, 2011 · regional
EP 11161954 · Apr 11, 2011 · regional
EP 11175732 · Jul 28, 2011 · regional
Continuity (1)
Related Publication 20130330632A1 · Dec 12, 2013